Typically, the patients received a reperfusion therapy (onset-to-treatment (OTT): MT and/or tPA) later than 3 h of stroke onset (52.6%; 3.2 ± 1.2 h, interquartile range 1 h 54 min). The gene discussed is PLAT; the disease is stroke disorder.